SEC Tracker
Get the app

Actuate Therapeutics ACTU

Actuate Therapeutics closes $9.96M stock offering

Item 1.01 Enters material agreement, Item 8.01 Other events

Form
8-K
Filed
Importance
Major
  1. Issued 30,985,900 shares of common stock and 15,492,950 warrants
  2. Net proceeds of $9.96M after underwriting discounts and expenses
  3. Underwriter granted 45-day option to purchase additional shares and warrants

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Actuate Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Lite Strategy LITS public float $43M, Dec 31, 2025
  2. Actinium Pharmaceuticals ATNM public float $44M, Jun 30, 2025
  3. Fortress Biotech FBIO public float $44M, Jun 30, 2025
  4. CervoMed CRVO public float $40M, Jun 30, 2025
  5. Acumen Pharmaceuticals ABOS public float $45M, Jun 30, 2025